Chapter/Section Purchase

1 Study Coverage
1.1 Therapeutic Peptide Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Therapeutic Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Peptide Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Peptide Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Peptide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Peptide Sales by Region
2.4.1 Global Therapeutic Peptide Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic Peptide by Region (2023-2028)
2.5 Global Therapeutic Peptide Revenue by Region
2.5.1 Global Therapeutic Peptide Revenue by Region (2017-2022)
2.5.2 Global Therapeutic Peptide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic Peptide Sales by Manufacturers
3.1.1 Global Top Therapeutic Peptide Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic Peptide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Peptide in 2021
3.2 Global Therapeutic Peptide Revenue by Manufacturers
3.2.1 Global Therapeutic Peptide Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic Peptide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Peptide Revenue in 2021
3.3 Global Therapeutic Peptide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic Peptide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic Peptide Sales by Type
4.1.1 Global Therapeutic Peptide Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic Peptide Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic Peptide Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Peptide Revenue by Type
4.2.1 Global Therapeutic Peptide Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic Peptide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic Peptide Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Peptide Price by Type
4.3.1 Global Therapeutic Peptide Price by Type (2017-2022)
4.3.2 Global Therapeutic Peptide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic Peptide Sales by Application
5.1.1 Global Therapeutic Peptide Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic Peptide Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic Peptide Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Peptide Revenue by Application
5.2.1 Global Therapeutic Peptide Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic Peptide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic Peptide Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Peptide Price by Application
5.3.1 Global Therapeutic Peptide Price by Application (2017-2022)
5.3.2 Global Therapeutic Peptide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic Peptide Market Size by Type
6.1.1 North America Therapeutic Peptide Sales by Type (2017-2028)
6.1.2 North America Therapeutic Peptide Revenue by Type (2017-2028)
6.2 North America Therapeutic Peptide Market Size by Application
6.2.1 North America Therapeutic Peptide Sales by Application (2017-2028)
6.2.2 North America Therapeutic Peptide Revenue by Application (2017-2028)
6.3 North America Therapeutic Peptide Market Size by Country
6.3.1 North America Therapeutic Peptide Sales by Country (2017-2028)
6.3.2 North America Therapeutic Peptide Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic Peptide Market Size by Type
7.1.1 Europe Therapeutic Peptide Sales by Type (2017-2028)
7.1.2 Europe Therapeutic Peptide Revenue by Type (2017-2028)
7.2 Europe Therapeutic Peptide Market Size by Application
7.2.1 Europe Therapeutic Peptide Sales by Application (2017-2028)
7.2.2 Europe Therapeutic Peptide Revenue by Application (2017-2028)
7.3 Europe Therapeutic Peptide Market Size by Country
7.3.1 Europe Therapeutic Peptide Sales by Country (2017-2028)
7.3.2 Europe Therapeutic Peptide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Peptide Market Size by Type
8.1.1 Asia Pacific Therapeutic Peptide Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic Peptide Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Peptide Market Size by Application
8.2.1 Asia Pacific Therapeutic Peptide Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic Peptide Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Peptide Market Size by Region
8.3.1 Asia Pacific Therapeutic Peptide Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic Peptide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Therapeutic Peptide Market Size by Type
9.1.1 Latin America Therapeutic Peptide Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic Peptide Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Peptide Market Size by Application
9.2.1 Latin America Therapeutic Peptide Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic Peptide Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Peptide Market Size by Country
9.3.1 Latin America Therapeutic Peptide Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic Peptide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Peptide Market Size by Type
10.1.1 Middle East and Africa Therapeutic Peptide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic Peptide Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Peptide Market Size by Application
10.2.1 Middle East and Africa Therapeutic Peptide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic Peptide Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Peptide Market Size by Country
10.3.1 Middle East and Africa Therapeutic Peptide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic Peptide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Ipsen
11.3.1 Ipsen Corporation Information
11.3.2 Ipsen Overview
11.3.3 Ipsen Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ipsen Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ipsen Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Corporation Information
11.6.2 Novo Nordisk Overview
11.6.3 Novo Nordisk Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novo Nordisk Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novo Nordisk Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Corporation Information
11.8.2 Johnson and Johnson Overview
11.8.3 Johnson and Johnson Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson and Johnson Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson and Johnson Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Teva
11.10.1 Teva Corporation Information
11.10.2 Teva Overview
11.10.3 Teva Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
11.11 Takeda
11.11.1 Takeda Corporation Information
11.11.2 Takeda Overview
11.11.3 Takeda Therapeutic Peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Takeda Therapeutic Peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic Peptide Industry Chain Analysis
12.2 Therapeutic Peptide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Peptide Production Mode & Process
12.4 Therapeutic Peptide Sales and Marketing
12.4.1 Therapeutic Peptide Sales Channels
12.4.2 Therapeutic Peptide Distributors
12.5 Therapeutic Peptide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic Peptide Industry Trends
13.2 Therapeutic Peptide Market Drivers
13.3 Therapeutic Peptide Market Challenges
13.4 Therapeutic Peptide Market Restraints
14 Key Findings in The Global Therapeutic Peptide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer